ZNG1F

gene
On this page

Also known as OTTHUMG00000066820OTTHUMG00000067194

Summary

ZNG1F (Zn regulated GTPase metalloprotein activator 1F, HGNC:31978) is a protein-coding gene on chromosome 9p11.2, encoding Zinc-regulated GTPase metalloprotein activator 1F (Q4V339). Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them.

Predicted to enable GTP binding activity; hydrolase activity; and metal ion binding activity. Predicted to be located in nucleus. Predicted to be active in cytoplasm.

Source: NCBI Gene 644019 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 41 total
  • MANE Select transcript: NM_001085457

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31978
Approved symbolZNG1F
NameZn regulated GTPase metalloprotein activator 1F
Location9p11.2
Locus typegene with protein product
StatusApproved
AliasesOTTHUMG00000066820, OTTHUMG00000067194
Ensembl geneENSG00000215126
Ensembl biotypeprotein_coding
Entrez644019

Gene structure

Transcript identifiers

Ensembl transcripts: 27 — 12 protein_coding, 6 nonsense_mediated_decay, 6 protein_coding_CDS_not_defined, 3 retained_intron

ENST00000377391, ENST00000382436, ENST00000456520, ENST00000457288, ENST00000467791, ENST00000486387, ENST00000490294, ENST00000494538, ENST00000610358, ENST00000610377, ENST00000611553, ENST00000613125, ENST00000613716, ENST00000617722, ENST00000617917, ENST00000620776, ENST00000622791, ENST00000894097, ENST00000894098, ENST00000894099, ENST00000894100, ENST00000894101, ENST00000894102, ENST00000894103, ENST00000894104, ENST00000894105, ENST00000958079

RefSeq mRNA: 3 — MANE Select: NM_001085457 NM_001085457, NM_001386876, NM_001386877

CCDS: CCDS43827

Canonical transcript exons

ENST00000377391 — 15 exons

ExonStartEnd
ENSE000016043944113130941131840
ENSE000018852244118910541189317
ENSE000040129054118356441183660
ENSE000040129064116233341162377
ENSE000040129074118599341186079
ENSE000040129084114528141145332
ENSE000040129094118237541182466
ENSE000040129104117429341174352
ENSE000040129114113367441133742
ENSE000040129124113222841132357
ENSE000040129134116678441166830
ENSE000040129144117271241172749
ENSE000040129154113350541133570
ENSE000040129164115638341156439
ENSE000040129174116500141165087

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 91.60.

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cerebellar cortexUBERON:000212991.60gold quality
cerebellar hemisphereUBERON:000224591.60gold quality
cerebellumUBERON:000203791.38gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047390.93gold quality
right hemisphere of cerebellumUBERON:001489090.93gold quality
Brodmann (1909) area 9UBERON:001354088.92gold quality
superior frontal gyrusUBERON:000266188.91gold quality
primary visual cortexUBERON:000243688.79gold quality
lower esophagus mucosaUBERON:003583488.03gold quality
granulocyteCL:000009487.72gold quality
right uterine tubeUBERON:000130287.49gold quality
right frontal lobeUBERON:000281087.17gold quality
dorsolateral prefrontal cortexUBERON:000983487.13gold quality
nucleus accumbensUBERON:000188287.01gold quality
adenohypophysisUBERON:000219686.97gold quality
olfactory segment of nasal mucosaUBERON:000538686.56gold quality
pituitary glandUBERON:000000786.55gold quality
skin of abdomenUBERON:000141686.40gold quality
skin of legUBERON:000151186.32gold quality
body of pancreasUBERON:000115086.29gold quality
zone of skinUBERON:000001486.28gold quality
Ammon’s hornUBERON:000195486.26gold quality
caudate nucleusUBERON:000187386.12gold quality
mucosa of transverse colonUBERON:000499185.95gold quality
putamenUBERON:000187485.90gold quality
anterior cingulate cortexUBERON:000983585.86gold quality
brainUBERON:000095585.68gold quality
cortex of kidneyUBERON:000122585.14gold quality
spleenUBERON:000210685.03gold quality
small intestine Peyer’s patchUBERON:000345484.95gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes19.19
E-MTAB-6524no17.84
E-HCAD-31no2.03

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

51 targeting ZNG1F, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3924100.0072.092394
HSA-MIR-340-5P100.0072.504437
HSA-MIR-428299.9975.366408
HSA-MIR-56899.9869.862084
HSA-MIR-548AB99.9571.313488
HSA-MIR-55999.9572.283609
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AD-5P99.9471.233502
HSA-MIR-548AE-5P99.9471.233502
HSA-MIR-548AK99.9471.243488
HSA-MIR-548AM-5P99.9471.243488
HSA-MIR-548AP-5P99.9471.143489
HSA-MIR-548AQ-5P99.9471.343426
HSA-MIR-548AR-5P99.9471.283515
HSA-MIR-548AS-5P99.9471.223482
HSA-MIR-548AU-5P99.9471.243488
HSA-MIR-548AY-5P99.9471.233502
HSA-MIR-548B-5P99.9471.233502
HSA-MIR-548BB-5P99.9471.273509
HSA-MIR-548C-5P99.9471.243488
HSA-MIR-548D-5P99.9471.233502
HSA-MIR-548H-5P99.9471.243488
HSA-MIR-548I99.9471.253481
HSA-MIR-548J-5P99.9471.143489
HSA-MIR-548O-5P99.9471.243488
HSA-MIR-548W99.9471.243488
HSA-MIR-548Y99.9471.283514
HSA-MIR-101-3P99.9475.032230
HSA-MIR-380-3P99.8970.181978
HSA-MIR-221-3P99.8671.561329

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriocbwdENSDARG00000004318
mus_musculusZng1ENSMUSG00000024878
rattus_norvegicusZng1aENSRNOG00000015516

Paralogs (4): ZNG1B (ENSG00000136682), ZNG1E (ENSG00000147996), ZNG1A (ENSG00000172785), ZNG1C (ENSG00000196873)

Protein

Protein identifiers

Zinc-regulated GTPase metalloprotein activator 1FQ4V339 (reviewed: Q4V339)

Alternative names: Cobalamin synthase W domain-containing protein 6

All UniProt accessions (8): A0A087WU66, A0A087WX94, A0A087X1C0, A0A0B4J2E3, Q4V339, F2Z3P0, H0Y5V3, Q5JTY2

UniProt curated annotations — full annotation on UniProt →

Function. Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them. Catalyzes zinc insertion into the active site of methionine aminopeptidase METAP1, which function to cleave the initiator methionine from polypeptides during or after protein translation. Mechanistically, the N-terminal psi-PxLVp motif binds to the C6H2-type zinc finger of inactive form of METAP1. After formation of the docked complex, zinc is transferred from the CXCC motif in the GTPase domain of ZNG1F to the zinc binding site in the peptidase domain of METAP1 in a process requiring GTP hydrolysis. GTP/GDP exchange is required for release of active METAP1.

Subcellular location. Nucleus.

Similarity. Belongs to the SIMIBI class G3E GTPase family. ZNG1 subfamily.

RefSeq proteins (3): NP_001078926, NP_001373805, NP_001373806 (=MANE)

Domains & families (InterPro)

IDNameType
IPR003495CobW/HypB/UreG_nucleotide-bdDomain
IPR011629CobW-like_CDomain
IPR027417P-loop_NTPaseHomologous_superfamily
IPR036627CobW-likC_sfHomologous_superfamily
IPR051316Zinc-reg_GTPase_activatorFamily

Pfam: PF02492, PF07683

Catalyzed reactions (Rhea), 1 shown:

  • GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)

UniProt features (12 total): binding site 6, short sequence motif 2, chain 1, domain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q4V339-F175.860.35

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (6): 110; 203–206; 49–56; 107; 109; 110–114

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 34 (showing top): chr9p11, GOBP_PROTEIN_MATURATION, GOMF_METALLOCHAPERONE_ACTIVITY, GOMF_MOLECULAR_CARRIER_ACTIVITY, NFE2L2.V2, MIR559, MIR548Y, MIR548BB_5P, MIR548AR_5P, MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P, MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P, MIR548O_5P_MIR548W, MIR548AB, MIR548AS_5P, MIR548A_5P

GO Biological Process (0):

GO Molecular Function (4): GTP binding (GO:0005525), hydrolase activity (GO:0016787), metal ion binding (GO:0046872), nucleotide binding (GO:0000166)

GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
guanyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
catalytic activity1
cation binding1
nucleoside phosphate binding1
heterocyclic compound binding1
intracellular membrane-bounded organelle1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

286 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNG1FSETD2Q9BYW2549
ZNG1FANKRD20A3PQ5VUR7544
ZNG1FFAM72CH0Y354491
ZNG1FFAM72BQ86X60484
ZNG1FANKRD20A2PQ5SQ80479
ZNG1FANKRD20A4PQ4UJ75477
ZNG1FHSPB3Q12988469
ZNG1FFAM72DQ6L9T8449
ZNG1FANKRD20A1Q5TYW2435
ZNG1FZNF836Q6ZNA1430
ZNG1FFAM72AQ5TYM5427
ZNG1FABRAQ8N0Z2413
ZNG1FDHRS4L2Q6PKH6400
ZNG1FB8ZZ87B8ZZ87379
ZNG1FTBC1D19Q8N5T2370

IntAct

18 interactions, top by confidence:

ABTypeScore
RNASEH2CRNASEH2Apsi-mi:“MI:0914”(association)0.640
KLK5DENND11psi-mi:“MI:0914”(association)0.640
ILVBLSLC33A1psi-mi:“MI:0914”(association)0.530
ECE1ZNG1Fpsi-mi:“MI:0915”(physical association)0.370
ZNG1BTCERG1psi-mi:“MI:0914”(association)0.350
ZNG1AAGAP1psi-mi:“MI:0914”(association)0.350
HDAC7ZMYM6psi-mi:“MI:0914”(association)0.350
ELK1TPP1psi-mi:“MI:0914”(association)0.350
ELK1PPP6Cpsi-mi:“MI:0914”(association)0.350
Mpsi-mi:“MI:0914”(association)0.350
MRPL27psi-mi:“MI:0914”(association)0.350
ZNG1BNME4psi-mi:“MI:0914”(association)0.350
ZNG1ATCERG1psi-mi:“MI:0914”(association)0.350
FAM170ARPSA2psi-mi:“MI:0914”(association)0.350
DTWD2ATP1A3psi-mi:“MI:0914”(association)0.350
P/VESYT2psi-mi:“MI:0914”(association)0.350

BioGRID (11): CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Reconstituted Complex), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS), CBWD6 (Affinity Capture-MS)

ESM2 similar proteins: A0A078BQP2, A0A131MCZ8, A0JN54, A3KGB4, A3QM97, A8WPG9, G5ED05, O16715, O88673, P11528, P20192, P23743, P23897, P25092, P30733, P33530, P49619, P49620, P49621, P51556, P55141, P55204, P70106, P90895, P91550, Q03603, Q09435, Q0IIM8, Q10029, Q17586, Q19954, Q22949, Q23681, Q3UWA6, Q4V339, Q4V3C7, Q5JTY5, Q5RIA9, Q618H8, Q67XQ0

Diamond homologs: B0R0B1, O74310, P24203, P31521, P33030, P53729, P94400, Q4V339, Q5JTY5, Q5RIA9, Q8IUF1, Q8VEH6, Q99MB4, Q9BRT8, P22042, P29937, Q869Q0, Q9HZQ2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

41 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance32
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1398 predictions. Top by Δscore:

VariantEffectΔscore
9:41131837:CTGC:Cacceptor_gain1.0000
9:41131841:C:CCacceptor_gain1.0000
9:41132221:GACTT:Gdonor_loss1.0000
9:41132222:ACTT:Adonor_loss1.0000
9:41132223:CTT:Cdonor_loss1.0000
9:41132224:TTA:Tdonor_loss1.0000
9:41132225:TA:Tdonor_loss1.0000
9:41132226:A:ACdonor_gain1.0000
9:41132226:A:Cdonor_loss1.0000
9:41132226:AC:Adonor_gain1.0000
9:41132227:C:CTdonor_gain1.0000
9:41132227:CC:Cdonor_gain1.0000
9:41132227:CCA:Cdonor_gain1.0000
9:41132227:CCAA:Cdonor_gain1.0000
9:41132227:CCAAT:Cdonor_gain1.0000
9:41133699:T:TAdonor_gain1.0000
9:41133739:TACT:Tacceptor_gain1.0000
9:41133740:ACTCT:Aacceptor_loss1.0000
9:41133741:CT:Cacceptor_gain1.0000
9:41133743:C:Aacceptor_loss1.0000
9:41133743:C:CCacceptor_gain1.0000
9:41133744:T:Gacceptor_loss1.0000
9:41133751:C:CTacceptor_gain1.0000
9:41133752:A:Tacceptor_gain1.0000
9:41164983:A:Cdonor_gain1.0000
9:41182369:TCTTA:Tdonor_loss1.0000
9:41182370:CTTA:Cdonor_loss1.0000
9:41182371:TTACC:Tdonor_loss1.0000
9:41182372:TACCA:Tdonor_loss1.0000
9:41182373:A:AGdonor_loss1.0000

AlphaMissense

2598 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:41165052:T:AK204I0.982
9:41133566:A:GL297P0.978
9:41131831:A:GL364S0.973
9:41132233:A:GL359P0.972
9:41132317:A:TV331D0.969
9:41131840:C:TG361D0.968
9:41132236:A:TV358D0.967
9:41133505:C:AK317N0.965
9:41133505:C:GK317N0.965
9:41156403:A:CF248L0.964
9:41156403:A:TF248L0.964
9:41156405:A:GF248L0.964
9:41131816:A:GL369P0.957
9:41133509:A:GL316P0.957
9:41132357:C:GG318R0.956
9:41132357:C:TG318R0.956
9:41131840:C:AG361V0.954
9:41132242:C:GR356P0.954
9:41133732:G:AT276I0.950
9:41165070:T:AD198V0.946
9:41133680:A:CF293L0.945
9:41133680:A:TF293L0.945
9:41133682:A:GF293L0.945
9:41132228:C:GG361R0.943
9:41165051:T:AK204N0.943
9:41165051:T:GK204N0.943
9:41132356:C:TG318E0.941
9:41133512:C:GR315T0.937
9:41132244:A:CN355K0.936
9:41132244:A:TN355K0.936

dbSNP variants (sampled 300 via entrez): RS1000201935 (9:41145888 G>A), RS1000453851 (9:41184651 C>T), RS1000506989 (9:41150829 C>T), RS1000535819 (9:41150449 C>A,T), RS1000659552 (9:41169468 G>A), RS1000725796 (9:41161095 C>A), RS1000787162 (9:41190097 T>C), RS1001046831 (9:41134212 A>G,T), RS1001094430 (9:41166787 G>A), RS1001188971 (9:41162318 G>T), RS1001295075 (9:41185205 G>A), RS1001465984 (9:41132028 A>G), RS1001497142 (9:41130941 G>T), RS1001520252 (9:41133863 A>C,G), RS1001730774 (9:41147548 CTA>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
fenpyroximatedecreases expression1
4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamidedecreases expression1
abrineincreases expression1
jinfukangdecreases expression1
Antimycin Adecreases expression1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.